Results 71 to 80 of about 6,902 (197)

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell Lymphoma

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT Primary mediastinal large B‐cell lymphoma (PMBL) is a rare entity that predominantly affects young female patients and typically presents as a large and compressive anterior mediastinal mass. Accumulating evidence suggests relationships among PMBL patient body composition (BC), cancer outcomes, and treatment‐related toxicities. The aim of this
Juliette Penichoux, Pierre Decazes, Cédric Rossi, Pierre Sesques, Corinne Haioun, Eric Durot, Nicolas Gower, Alexandre Willaume, Lucie Oberic, Jérome Paillassa, Chloé Antier, Loic Renaud, Olivier Tournilhac, Catherine Thieblemont, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Roch Houot, Adrien Chauchet, Stéphanie Becker, David Tonnelet, Hervé Tilly, Fabrice Jardin, Emilie Lévêque, Vincent Camus   +29 more
wiley   +1 more source

Massive circulating metastatic cells: A case of carcinocythemia

Clinical Case Reports
Key Clinical Message Importance of careful differential diagnosis to make the distinction between carcinocythemia and acute leukemia or lymphoma.
Carine Farkh, Jérome Debus, Valérie Andrieu, Juliette Gay   +3 more
doaj   +1 more source

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy

Haematologica, 2018
Evading immune eradication is a prerequisite for neoplastic progression and one of the hallmarks of cancer. Here, we review the different immune escape strategies of lymphoma and classify them into two main mechanisms. First, lymphoma cells may “hide” to
Marie de Charette, Roch Houot
doaj   +1 more source

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials [PDF]

, 2018
info:eu-repo/semantics ...
Benoit, Yves, Bertrand, Y, Cave, H, Chantrain, C, Clappier, E, Costa, V, Dastugue, N, Dresse, M-F, Drunat, S, Ferster, A, Freycon, C, Gilotay, C, Girard, S, Grardel, N, Lutz, P, Mazingue, F, Millot, F, Minckes, O, Norga, K, Piette, C, Plat, G, Pluchart, C, Poiree, M, Rohrlich, P-S, Simon, P, Sirvent, N, Suciu, S, Uyttebroeck, A, van der Werff ten Bosch, J, Van Roy, Nadine, Yakouben, K   +30 more
core   +2 more sources

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Haematologica, 2018
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto   +13 more
doaj   +1 more source

What is the translation of the Hopkins Symptom Checklist in 25 items into Croatian? A Delphi consensus procedure for forward-backward translation

, 2014
Introduction. In Europe, depression is the second most common chronic disease in primary care. To diagnose depression in family practice, European experts in primary care selected by consensus the Hopkins Symptom CheckList in 25 items (HSCL-25).
Dargère, Marine
core  

P-085: THE MORBIDITY AND MORTALITY OF SICKLE CELL DISEASE PATIENTS IN THE HAEMATOLOGY DEPARTMENT OF THE IGNACE DEEN HOSPITAL, CONAKRY HOSPITAL AND UNIVERSITY CENTRE

HemaSphere, 2022
DIAKITE M., GUILAVOGUI F., KANTE A., CONDE A., SYLLA M., TOUNKARA T.   +5 more
doaj   +1 more source

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia

Molecular Oncology, 2018
Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic‐phase CML (CP‐CML ...
Stéphanie Maupetit‐Mehouas, Franck Court, Céline Bourgne, Agnès Guerci‐Bresler, Pascale Cony‐Makhoul, Hyacinthe Johnson, Gabriel Etienne, Philippe Rousselot, Denis Guyotat, Alexandre Janel, Eric Hermet, Sandrine Saugues, Juliette Berger, Philippe Arnaud, Marc G. Berger   +14 more
doaj   +1 more source

Soluble HLA-G Molecules Are Increased during Acute Leukemia, Especially in Subtypes Affecting Monocytic and Lymphoid Lineages'

Neoplasia: An International Journal for Oncology Research, 2006
Human leukocyte antigen G (HLA-G) molecules corresponding to nonclassic class I genes of the major histocompatibility complex exhibit immunomodulatory properties.
Frédéric Gros, Yasmine Sebti, Sophie de Guiber, Bernard Branger, Marc Bernard, Renée Fauchet, Laurence Amiot   +6 more
doaj   +1 more source

Créer une communauté de chefs de service pour répondre aux défis du système hospitalier : première expérience en hématologie

Bulletin du Cancer, 2023
R. Houot, J. Bay, P. Chevallier, S. Choquet, L. Fornecker, J. Ianotto, A. Jaccard, F. Jardin, L. Legros, F. Lemonnier, Sophie Park, L. Pascal, C. Soussain, E. Gyan   +13 more
semanticscholar   +1 more source